Select Vaccines Limited (SLT) is focused on the
development of products targeting infectious diseases caused
by viruses. The company's Virus Like Particle (VLP)
vaccine technology provides a platform that can deliver a
range of vaccine candidates and offers significant potential
advantages over existing VLP technologies.